I'm doing research on the GLP-1 connection with papillary right now, because I see patients with thyroid cancer who have obesity and they're at high risk for recurrent thyroid cancer
NAD+ Injections with NMN and 5-Amino-1MQ provide a strategy for replenishing these essential molecules while enhancing how efficiently the body uses them
A meaningful subset of patients don't respond significantly
[33] [34] In 2026, the UK Medicines and Healthcare products Regulatory Agency (MHRA) updated its guidance on GLP-1 medication after an increase in reports to the agency's Yellow Card Scheme of acute pancreatitis, with fatalities, in patients taking semaglutide or tirzepatide, to warn of a small risk of developing severe acute pancreatitis
For any lab venturing into this territory, the journey must begin with an unwavering foundation of quality
This is the part most people miss: the copper uglies is an adjustment phase, not "ruined" skin